SPGP Invesco S&P 500 GARP ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| HST | 2.65% |
| NVDA | 2.58% |
| DAL | 2.39% |
| MPWR | 2.31% |
| RCL | 2.30% |
| UBER | 2.27% |
| ABNB | 2.20% |
| CCL | 2.08% |
| ANET | 2.01% |
| BKR | 2.00% |
ETF Analysis
Fund Overview
Invesco S&P 500 GARP ETF (SPGP) currently reports 74 stock positions (subject to change), placing it in the balanced in breadth range by holdings breadth. The top line-up is HST (2.65%), NVDA (2.58%), DAL (2.39%), with HST as the largest single weight at 2.65%. Together, the top three holdings account for 7.62%, which reflects a construction where the top positions carry meaningful but not outsized influence on aggregate returns. In aggregate, the construction reflects a balance between directional conviction and the diversification benefits that come from a broader holding set.
Profitability & Capital Efficiency
On the question of capital productivity, ROIC is 32.37%, WACC is 9.42%, and the economic spread is 22.95%. On balance, the economic spread is positive and meaningful, suggesting the underlying holdings are building rather than eroding intrinsic value. Supporting metrics show ROE at 37.85% and ROA at 11.13%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.
Valuation
On a multiple basis, the portfolio trades at trailing P/E of 17.48, forward P/E of 15.15, PEG of 2.43. Forward P/E is broadly in line with trailing, suggesting analysts are not projecting a material change in profitability over the coming year. At this PEG level, valuation is defensible given the growth outlook, though there is limited margin of safety against estimate disappointments. The portfolio carries an aggregate current ratio of 1.78, consistent with adequate near-term liquidity management. The valuation setup is broadly consistent with a market that is pricing growth without being reckless about it — a balanced but not cautious stance.
Margins & Cash Generation
The margin stack reads as follows: gross margin sits at 49.79%, operating margin at 25.77%, and free cash flow margin at 22.30%. The gross margin reading points to holdings with solid but not outsized pricing power relative to direct costs. The portfolio's operating margins are solid, pointing to holdings where overhead management is a relative strength. FCF margins are constructive here, reflecting holdings that generate cash reliably after reinvestment requirements. The margin profile is a mixed read — some holdings are clearly well-run, but the aggregate numbers point to a basket that is not uniformly high-quality.
Growth & Forward Outlook
Where growth and expectations intersect, the estimated 12-month price change of 23.29%, where analyst assumptions support a moderate upside case if execution remains steady, while TTM revenue growth of 13.66% suggesting the portfolio's holdings are growing revenues at a measured, sustainable pace. The projected 12-month EPS growth rate of 15.4% is a standout component of the forward case — meaningful earnings expansion at this scale typically warrants attention from growth-oriented investors. Both signals are useful lenses, but they tend to diverge most sharply near inflection points in both business fundamentals and market sentiment. The durability of both the operating trend and analyst optimism will determine whether the current setup translates into measurable near-term returns. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
Strong BuyPutting all the pieces together, the fundamental picture is one of the more convincing setups in these metrics — strong capital returns, reasonable pricing, and a healthy forward outlook.
The views expressed above are derived from quantitative data only and should not be relied upon as financial advice. Investment decisions should be based on your own research and risk tolerance.